-
Understanding Drug Pricing Around The Globe
Apr 8, 2020, 00:00 AM -
Patient-Preference Information – What It Is and What It Is Not
Mar 4, 2020, 12:00 PM -
Overview of Multi-criteria Decision Analysis (MCDA) & Its applications in Health Technology Assessment (HTA)
Feb 5, 2020, 14:33 PM -
Economic Evaluation of Vaccination Programs
Jan 15, 2020, 10:30 AM -
Pharmaceutical reimbursement policy and system in Sweden and Denmark - Current practice and recent reforms
Nov 20, 2019, 10:00 AM -
Precision Medicine and Advanced Therapies 101
Oct 23, 2019, 11:00 AM -
Real-World Epidemiologic Studies in Pharmaceutical Industry
Oct 23, 2019, 10:00 AM -
Value translation from bench to market: Strategy and analytics to proactively address access hurdles from early stage development
Oct 15, 2019, 08:04 AM -
“Cure”-ious about mixture models? Accounting for heterogeneity in survival extrapolation
Oct 10, 2019, 07:56 AM -
Going abroad during your studies to jump start your career: why, how, and what
Oct 1, 2019, 11:00 AM -
Good Practices for HTA - What is out there and how do I use it
Sep 16, 2019, 16:41 PM -
Principles of Machine Learning for Prediction
Jul 30, 2019, 12:00 PM -
Topics in Evaluating the Cost-Effectiveness of Gene Therapies
May 29, 2019, 13:00 PM -
Is the FDA's New Guidance a Watershed Moment for Real-world Evidence?
May 1, 2019, 13:04 PM -
An Introduction to Pharmacovigilance
Apr 17, 2019, 10:17 AM -
MCDA - How to Guide Through the Application of Different Methods for Assessment and Prioritization of Rare Disease Health Technologies
Apr 4, 2019, 09:02 AM -
The Use of MCDA for HTA Agencies – Options, Limitations and the Way Forward
Apr 3, 2019, 09:00 AM -
Virtualizing Long-Term Follow-Up Studies for Gene Therapy Products
Mar 27, 2019, 08:50 AM -
Using RWE to Improve Healthcare Decision-making in Asia Pacific
Mar 25, 2019, 09:00 AM -
Top 10 Trends in Health Economics and Outcomes Research - 2019
Mar 22, 2019, 09:00 AM